PURPOSE: In this systematic review, we assessed the therapeutic efficacy and safety of Clostridium Histolyticum Collagenase (CCH) and Tissue Subcision (TS) for treating cellulite, which ranges from subtle to pronounced lesions.
METHODS: A systematic review was performed following PRISMA guidelines for CCH and TS treatment to the thigh and gluteal regions. A proportion meta-analysis was then conducted using Stata statistical software.
RESULTS: A total of 14 studies were incorporated into the final analysis. Nine focused on TS and five on CCH injection, collectively reporting outcomes for 1254 patients. Of these, 465 received CCH injection and 789 underwent subcision. For bruising, rates were 89% [CI: 71-96%] with CCH injection and 99% [CI: 85-99%] for subcision; pain requiring analgesic was reported at 74% [CI: 55-87%] for CCH and 60% [CI: 43-76%] for subcision; both showed induration at 7% [CI: 5-11% for CCH, 2-25% for subcision], while skin discoloration was higher post-CCH injection at 16% [CI: 10-26%] compared to 7% [CI: 5%-10%] post-subcision.
CONCLUSION: Both CCH and TS appear effective treatments for cellulite. However, upon evaluating the adverse outcomes between the two modalities, subcision demonstrated a higher incidence of bruising, albeit similar rates of induration compared to CCH injection. Conversely, the CCH injection group manifested a higher propensity for pain requiring analgesia and notably exhibited increased instances of skin discoloration compared to their subcision patient group. Further standardized research is crucial for more informed cellulite treatment decisions and for comparing efficacy, safety, and cost-effectiveness between tissue subcision and CCH.